Browsing Tag: Drugs and Cosmetics Act 1940

Key Highlights:  Implications:  This curbs aggressive GLP-1 marketing (e.g., Ozempic/Wegovy), protecting India’s $115M diabetes/obesity segment from off-label hype amid 101M diabetics....